Lorillard Inc

Lorillard — Debt Investor Presentation (April 2010)

25 slides from Lorillard's debt investor presentation, Apr 7, 2010

  1. Slide 1: Senior Notes Offering April 2010

    Senior Notes Offering April 2010 Lorillard, Inc. has filed a preliminary prospectus supplement and registration statement with the SEC relating to an offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement and registration statement on F

  2. Slide 2: The Offering

    The Offering Issuer: Lorillard Tobacco Company Guarantor: Lorillard, Inc. Security: Senior Unsecured Notes Offering: SEC Registered Size: Benchmark Ratings: Baa2 / BBB- (Stable / Negative) Use of Proceeds: General Corporate Purposes, which may include the repurchase, redemption or retirement of secu

  3. Slide 3: Safe Harbor Disclaimer

    Safe Harbor Disclaimer You are cautioned that certain statements made in this presentation are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may project, indicate or im

  4. Slide 4: Regulation G Compliance

    Regulation G Compliance You are also reminded that during this presentation, certain non-GAAP financial measures, such as EBITDA may be discussed. These measures should not be considered an alternative to net income, or any other measure of financial performance or liquidity presented in accordance

  5. Slide 5: Management Presenters

    Management Presenters David Taylor Executive Vice President, Finance and Planning and Chief Financial Officer

  6. Slide 6: Agenda

    Agenda Overview FDA Litigation Historical Financial Performance

  7. Slide 7: Lorillard Overview

    Lorillard Overview Third largest tobacco company in the United States Sell products only in the U.S., Puerto Rico and U.S. possessions Spun off from Loews Corporation in June 2008 Leading position in the two best performing categories in the cigarette market Strong brand portfolio led by the Newport

  8. Slide 8: Trends in the U.S. Cigarette Market

    Trends in the U.S. Cigarette Market Industry unit volume has declined at a 3.9% CAGR over the past seven years and declined 8.6% in 2009 Increases in federal and state excise taxes impacted recent trends Longer term trends unclear (billions of cigarettes shipped) 2002 - 2009 CAGR (3.9%) Source: Dome

  9. Slide 9: Strong Brand Portfolio is Led by Newport

    Strong Brand Portfolio is Led by Newport Source: Lorillard Shipment Data. Includes Old Gold, Maverick, Kent, True and Max brands. Accounted for 88.9% of domestic shipments in 2009 Newport (91.5% of sales) Primary driver of profitability Kent, True and Max Mature brands -- harvesting profit Premium B

  10. Slide 10: Operating Strategy

    Operating Strategy Continue to manage business with long-term perspective Continued focus on premium price segment via Newport Manage Maverick's growth in discount price segment to optimize brand profitability Harvest profits from all other brands Balance trade-off between Newport's market share gro

  11. Slide 11: Menthol Continues to Gain Share

    Menthol Continues to Gain Share As consumer preferences continue to evolve, Lorillard is best positioned to capitalize on that trend Source: Domestic wholesale shipments per MSAI (adjusted to exclude Camel Crush). 26.4% 26.7% 27.4% 27.9% 28.4% 28.8% 20.0% 21.0% 22.0% 23.0% 24.0% 25.0% 26.0% 27.0% 28

  12. Slide 12: Newport Leads the Menthol Segment

    Newport Leads the Menthol Segment 2004 2005 2006 2007 2008 2009 Newport 0.301 0.315 0.322 0.329 0.34 0.341 Marlboro Menthol 0.128 0.142 0.15 0.164 0.177 0.189 Kool 0.112 0.115 0.114 0.111 0.101 0.083 Salem 0.085 0.075 0.068 0.064 0.06 0.056 Camel Menthol 0.011 0.01 0.023 0.029 0.028 0.023 w/o blend

  13. Slide 13: Family Smoking Prevention and Tobacco Control Act

    Family Smoking Prevention and Tobacco Control Act Signed into law on June 22, 2009

  14. Slide 14: FDA Authority Key Dates

    FDA Authority Key Dates - General Obligations Publish 1996 Marketing and Sales Rule as Final Establish Center for Tobacco Products Establish 12-member Tobacco Products Scientific Advisory Committee FDA Obligation: To be effective June 22, 2010 Established 9 voting members and 3 non-voting members na

  15. Slide 15: Scientific Advisory Committee

    Scientific Advisory Committee Consider all matters related to tobacco - not just menthol Consideration of menthol cigarettes is first order of business Timing of recommendation to FDA Expected by March 2011 Due dates are frequently missed and postponed

  16. Slide 16: Litigation

    Leollliad Litigation

  17. Slide 17: Major Types of Litigation

    Class Actions/Mass Tort Cases Personal Injury/Reimbursement of Medical Expenses "Lights" (Low Tar) Individual Smoking and Health cases Standard individual cases W. Virginia consolidated individual case Broin flight attendant cases Engle "progeny" cases Kent Filter cases (Lorillard only) DOJ case: un

  18. Slide 18: Financial Results

    Leollliad Financial Results

  19. Slide 19: Financial Policy Highlights

    Financial Policy Highlights Uses for free cash flow Capital investment (~$50 million per year) Dividends (target payout ratio of 70 - 75% of earnings) Share repurchases - 3 programs completed since spin-off totaling $1.4 billion Potential acquisitions Capital structure Successfully completed first d

  20. Slide 20: Summary Historical Income Statement

    Summary Historical Income Statement Stable top-line and earnings profile

  21. Slide 21: Summary Historical Balance Sheet

    Summary Historical Balance Sheet

  22. Slide 22: Summary Historical Cash Flow Statement

    Summary Historical Cash Flow Statement Lorillard has a history of generating strong and sustainable cash flow

  23. Slide 23: Highlights

    Highlights Leader in the best performing segments of the cigarette market Significant Newport brand equity and customer loyalty Efficient business model and disciplined operating philosophy focused on optimizing profitability Track record of strong, stable and consistent cash flow generation Well-po

  24. Slide 24: Appendix A Regulation G Reconciliations

    Appendix A Regulation G Reconciliations Reconciliation of Net Income to EBITDA ($ in millions) 2007 2008 2009 Net Income $ 898 $ 887 $ 948 Add: Income Taxes 485 547 571 Other (Income) Expense, net Other (Income) Expense, net (109) (19) 22 Operating Income $ 1,274 $ 1,415 $ 1,541 Depreciation & Amort

  25. Slide 25: Thank You

    Leollliad Thank You

Lorillard — Debt Investor Presentation (April 2010) on 6ix